Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy-Reference-Cited by-同舟云学术

Discriminating α-synuclein strains in Parkinson’s disease and multiple system atrophy

Published:2020-02-05 Issue:7794 Volume:578 Page:273-277
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Shahnawaz Mohammad,Mukherjee Abhisek,Pritzkow Sandra,Mendez Nicolas,Rabadia Prakruti,Liu Xiangan,Hu Bo,Schmeichel Ann,Singer Wolfgang,Wu Gang,Tsai Ah-Lim,Shirani Hamid,Nilsson K. Peter R.,Low Phillip A.,Soto Claudio

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41586-020-1984-7.pdf

Reference41 articles.

1. Goedert, M., Jakes, R. & Spillantini, M. G. The synucleinopathies: twenty years on. J. Parkinsons Dis. 7, S51–S69 (2017).

2. Wenning, G. K. et al. What clinical features are most useful to distinguish definite multiple system atrophy from Parkinson’s disease? J. Neurol. Neurosurg. Psychiatry 68, 434–440 (2000).

3. Melki, R. Role of different alpha-synuclein strains in synucleinopathies, similarities with other neurodegenerative diseases. J. Parkinsons Dis. 5, 217–227 (2015).

4. Prusiner, S. B. et al. Evidence for α-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc. Natl Acad. Sci. USA 112, E5308–E5317 (2015).

5. Peng, C. et al. Cellular milieu imparts distinct pathological α-synuclein strains in α-synucleinopathies. Nature 557, 558–563 (2018).

Cited by 546 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Elucidating the electronic properties of 2,5-di(hetero)arylthiophenes bearing pyridine, thienyl, tolyl, and benzonitrile pending groups: An experimental and theoretical approach;Journal of Molecular Structure;2025-02

2. Combining salivary α-synuclein seeding activity and miRNA-29a to distinguish Parkinson's disease and multiple system atrophy;Parkinsonism & Related Disorders;2024-10

3. Particulate matter 2.5 accelerates aging: Exploring cellular senescence and age-related diseases;Ecotoxicology and Environmental Safety;2024-10

4. Bifunctional Inhibitor Lentinan Inhibits Fibrillogenesis of Amyloid-β Protein and α-Synuclein and Alleviates Their Cytotoxicity: In Vitro and In Vivo Studies;ACS Chemical Neuroscience;2024-09-12

5. Research advancement in fluid biomarkers for Parkinson’s disease;Expert Review of Molecular Diagnostics;2024-09-11